['glaucoma, neovascular']
['aflibercept (eylea, bay 86-5321)', 'sham injection']

        Inclusion Criteria:

          -  Japanese men and women aged 20 years or older,

          -  Patients diagnosed as having Neovascular glaucoma (NVG) with neovascularization in the
             anterior segment (both iris and anterior chamber angle),

          -  Patients with Intraocular pressure (IOP) higher than 25 mmHg in the study eye due to
             anterior segment (both iris and anterior chamber angle) neovascularization.

        Exclusion Criteria:

          -  Patients with angle-closure due to conditions other than Neovascular glaucoma

          -  Patients with a known or suspected ocular or peri-ocular infection,

          -  Patients with severe intraocular inflammation in the study eye,

          -  Women who are pregnant, suspected of being pregnant or lactating,

          -  Patients with known allergy to aflibercept.
      